Executive summary from the report: analysis of adverse reactions to monosodium glutamate (MSG)
D000284:Administration, Oral; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001249:Asthma / Q000139:chemically induced; D002490:Central Nervous System / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D018698:Glutamic Acid / Q000097:blood; D006801:Humans; D051379:Mice; D018673:Nutrition Policy; D010902:Pituitary Gland / Q000502:physiology; D011323:Primates; D012970:Sodium Glutamate / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D018698:Glutamic Acid; D012970:Sodium Glutamate